14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:CBLI
Delisted

Cleveland BioLabs Stock Price (Quote)

$0.240
+0.0060 (+2.56%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $0.202 $0.499 Friday, 27th May 2022 CBLI stock ended at $0.240. This is 2.56% more than the trading day before Thursday, 26th May 2022. During the day the stock fluctuated 8.70% from a day low at $0.230 to a day high of $0.250.
90 days $0.202 $1.06
52 weeks $0.202 $7.10

Historical Cleveland BioLabs prices

Date Open High Low Close Volume
Jan 04, 2022 $2.23 $2.28 $2.07 $2.14 132 979
Jan 03, 2022 $2.34 $2.38 $2.24 $2.27 81 771
Dec 31, 2021 $2.26 $2.32 $2.22 $2.30 170 875
Dec 30, 2021 $2.15 $2.28 $2.15 $2.24 192 012
Dec 29, 2021 $2.21 $2.24 $2.10 $2.15 149 871
Dec 28, 2021 $2.25 $2.25 $2.12 $2.16 221 766
Dec 27, 2021 $2.30 $2.30 $2.20 $2.23 163 423
Dec 23, 2021 $2.29 $2.32 $2.22 $2.29 158 367
Dec 22, 2021 $2.18 $2.42 $2.14 $2.28 330 188
Dec 21, 2021 $2.18 $2.25 $2.15 $2.24 169 420
Dec 20, 2021 $2.10 $2.20 $2.09 $2.20 137 966
Dec 17, 2021 $2.37 $2.37 $2.11 $2.20 319 044
Dec 16, 2021 $2.18 $2.45 $2.13 $2.35 271 799
Dec 15, 2021 $2.01 $2.18 $2.00 $2.10 192 033
Dec 14, 2021 $2.10 $2.20 $2.00 $2.01 270 514
Dec 13, 2021 $2.09 $2.19 $2.07 $2.07 244 615
Dec 10, 2021 $2.33 $2.37 $2.09 $2.09 318 156
Dec 09, 2021 $2.55 $2.60 $2.31 $2.31 102 434
Dec 08, 2021 $2.46 $2.59 $2.32 $2.55 205 164
Dec 07, 2021 $2.02 $2.79 $2.02 $2.41 1 078 103
Dec 06, 2021 $2.21 $2.23 $1.99 $2.01 372 681
Dec 03, 2021 $2.46 $2.50 $2.26 $2.30 204 599
Dec 02, 2021 $2.73 $2.80 $2.27 $2.50 313 326
Dec 01, 2021 $2.99 $2.99 $2.65 $2.69 814 247
Nov 30, 2021 $3.06 $3.27 $2.91 $2.94 177 206
Click to get the best stock tips daily for free!

About Cleveland BioLabs

Cleveland BioLabs Cleveland BioLabs, Inc., a biopharmaceutical company, focuses on developing pharmaceuticals designed to address diseases with unmet medical need. Its lead drug candidate includes Entolimod, a Toll-like receptor 5 (TLR5) agonist, which is used for the prevention of death from acute radiation syndrome, and is used as an oncology drug. The company is also developing CBLB612, a pharmacologically optimized synthetic molecule that structurally mimics n... CBLI Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT